Keftaaz HS 500 mg/62.5 mg Injection
Cefepime (500mg) + Tazobactum (62.5mg)
Primary uses of : Bacterial infections
-
-
-
*
-
|
Composition
|
Cefepime (500mg) + Tazobactum (62.5mg) |
|
Side Effect
|
Common
Diarrhoea, Injection site reaction, Injection site pain, Injection site inflammation, Allergic reaction, Rash. |
|
How to works
|
How Keftaaz HS Injection works
Keftaaz HS 500 mg/62.5 mg Injection is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria. |
